News 
Market Data 
Discover
Chief-money
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| BCLI | BrainStorm Cell Therapeutics Inc | 0.555 | 0.01 | 1.83% | 04/23/2018 | |||||
|
My BCLI Pitch: Stem cell company just entered Phase III clinical trial to treat ALS. MS, Parkinson and Alzheimer in pipeline. Just received no strings attached $16 million grant to fund phase III which is indication they expect positive results. This could be 100 X return with successful phase 3.
|
||||||||||
